Fundraising FoxCasdin Capital — 2016 Investments
2 investments dated 2016 · listed companies and verified rows first · show all
Flatiron Health combines AI-powered technology and clinical expertise with real-world oncology data to help healthcare providers and life science organizations improve cancer care and research.
AI & Machine LearningData & InfrastructureHealthtechMedical DevicesNew York, US
Nat Turner(Founder)inZachary Weinberg(Director, Executive Officer)Nathan Hubbard(Chief Executive Officer)inMichael Bierl(Chief Business Officer)inCal Brouilette(Chief Financial Officer)inAllison Candido(Chief Technology Officer)in
Co-investorsBoxGroupCarnrite VenturesFirst Round CapitalGreat Oaks Venture CapitalGV (Google Ventures)Stripes+7 more
Syros Pharmaceuticals is a Massachusetts gene-control biotech developing small molecules that regulate disease gene expression.
Cambridge, US
Nancy Simonian(CEO)
Co-investorsAisling CapitalARCH Venture PartnersQuan CapitalAlexandriaAlly Bridge GroupBain Capital+11 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.